Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can we end stigma in cancer care? a new study investigates

NCT ID NCT07748221

Knowledge-focused Sponsor: Istituto Oncologico Veneto IRCCS Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 05, 2026 · Last updated Sep 17, 2026 · Updated 3 times

Summary

This study asks whether healthcare providers in cancer centers hold negative attitudes toward patients with mental disorders, and what factors influence those views. Researchers will survey about 1,000 oncology professionals using a stigma questionnaire and interview some of them in depth. The goal is to understand how stigma might affect patient care and to inform future efforts to make cancer care more equitable.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could lead to better training and support for healthcare providers, reducing stigma and improving cancer care for patients with mental disorders.
What could go wrong
This is an observational study, so it won't directly test an intervention. The findings may not apply to all cancer centers, and self-reported attitudes may not reflect actual behavior.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 1,000 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Nov 2026

An estimate. Start dates often move.

Expected to finish

Mar 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population consists of healthcare professionals working in oncology settings at participating Italian cancer centres. Eligible participants include physicians, nurses, psychologists, radiation therapy technologists, and healthcare assistants directly involved in the care of oncology patients. Participants will be recruited through exhaustive sampling across participating institutions and invited to complete an anonymous survey. A purposive sample of survey participants may subsequently be invited to participate in semi-structured interviews as part of the qualitative phase of the study.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Healthcare professionals working in participating oncology centres. * Physicians, nurses, psychologists, radiation therapy technologists, and healthcare assistants. * Direct involvement in the clinical care of oncology patients. * Employed at one of the participating study sites at the time of enrolment. * Able to understand the study information and provide informed consent. * Willing to participate in the study. For the qualitative phase, a purposive sample of participants will be selected from survey respondents who agree to be contacted for a semi-structured interview. Exclusion Criteria: * Refusal to participate or failure to provide informed consent. * Students in training. * Healthcare personnel working in services with very limited patient contact and without direct responsibility for oncology patient care.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cancer neoplasm Psychological Well-Being Social Stigma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cancer Psychiatric comorbidity Stigma of mental illness

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    3 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Centro Riferimento Oncologico CRO IRCCS

    Aviano, 33081, Italy

  • Istituto Tumori IRCCS Giovanni Paolo II

    Bari, 70124, Italy

  • The Padua, Castelfranco Veneto, and Schiavonia campuses of the Veneto Institute of Oncology (IOV-IRCCS).

    Padova, 35128, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.